PHYTOMEDICINE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2168450, encodeId=9f872168450a0, content=偏重的研究方向：中药单体;心血管 经验分享：请问submitted状态要持续多久啊？我的已经2周没变过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Nov 14 13:52:58 CST 2023, time=2023-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122040, encodeId=eb54212204091, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：中药 经验分享：想请问大家，Under Editor Assessment这个状态卡了快一个月了，是什么意思呀，可以发邮件催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fc65556145, createdName=ms4000000742058182, createdTime=Mon Mar 27 11:02:07 CST 2023, time=2023-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=33分钟前, status=0, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理机制 经验分享：终于轮到我来分享经验l！这次投稿意料之外的快，可能是方向比较符合编辑的胃口，只送了一次外审，修回后就接收了，整个投稿流程也非常顺利，具体时间如下： * 11.08 submit * 11.11 改格式 * 11.14 under editor assessment * 11.15 reviewer invited + under review * 12.15 revise * 12.31 revise submit + with editor * 01.01 under editor assessment * 01.03 under review * 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191103, encodeId=96d6219110378, content=2.23日Under Editor Assessment 还没更新，会不会被拒。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4118494660, createdName=ms1000000105774578, createdTime=Tue Mar 05 09:29:50 CST 2024, time=2024-03-05, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿，现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：返修回去一个多月了，还是在邀请审稿人，难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片 12.25 submitted to journal 12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊，已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2139117, encodeId=8f50213911ec7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：请问Proof后多久才能出版呢，已经Proof两周了，没有动静，并且Pre-Online是未Proof版本，上周已邮件咨询过，回复是正在校稿，这快两周过去了，有知道情况的友友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eab8634806, createdName=ms6000000954293507, createdTime=Fri May 26 09:07:39 CST 2023, time=2023-05-26, status=1, ipAttribution=北京)]

2023-11-14 ms7000001909487480 来自北京

偏重的研究方向：中药单体;心血管
经验分享：请问submitted状态要持续多久啊？我的已经2周没变过了。

24 16

展开16条回复

[GetPortalCommentsPageByObjectIdResponse(id=2168450, encodeId=9f872168450a0, content=偏重的研究方向：中药单体;心血管 经验分享：请问submitted状态要持续多久啊？我的已经2周没变过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Nov 14 13:52:58 CST 2023, time=2023-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122040, encodeId=eb54212204091, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：中药 经验分享：想请问大家，Under Editor Assessment这个状态卡了快一个月了，是什么意思呀，可以发邮件催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fc65556145, createdName=ms4000000742058182, createdTime=Mon Mar 27 11:02:07 CST 2023, time=2023-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=33分钟前, status=0, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理机制 经验分享：终于轮到我来分享经验l！这次投稿意料之外的快，可能是方向比较符合编辑的胃口，只送了一次外审，修回后就接收了，整个投稿流程也非常顺利，具体时间如下： * 11.08 submit * 11.11 改格式 * 11.14 under editor assessment * 11.15 reviewer invited + under review * 12.15 revise * 12.31 revise submit + with editor * 01.01 under editor assessment * 01.03 under review * 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191103, encodeId=96d6219110378, content=2.23日Under Editor Assessment 还没更新，会不会被拒。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4118494660, createdName=ms1000000105774578, createdTime=Tue Mar 05 09:29:50 CST 2024, time=2024-03-05, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿，现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：返修回去一个多月了，还是在邀请审稿人，难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片 12.25 submitted to journal 12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊，已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2139117, encodeId=8f50213911ec7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：请问Proof后多久才能出版呢，已经Proof两周了，没有动静，并且Pre-Online是未Proof版本，上周已邮件咨询过，回复是正在校稿，这快两周过去了，有知道情况的友友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eab8634806, createdName=ms6000000954293507, createdTime=Fri May 26 09:07:39 CST 2023, time=2023-05-26, status=1, ipAttribution=北京)]

2023-03-27 ms4000000742058182 来自北京

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：中药
经验分享：想请问大家，Under Editor Assessment这个状态卡了快一个月了，是什么意思呀，可以发邮件催一下吗？

54 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2168450, encodeId=9f872168450a0, content=偏重的研究方向：中药单体;心血管 经验分享：请问submitted状态要持续多久啊？我的已经2周没变过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Nov 14 13:52:58 CST 2023, time=2023-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122040, encodeId=eb54212204091, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：中药 经验分享：想请问大家，Under Editor Assessment这个状态卡了快一个月了，是什么意思呀，可以发邮件催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fc65556145, createdName=ms4000000742058182, createdTime=Mon Mar 27 11:02:07 CST 2023, time=2023-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=33分钟前, status=0, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理机制 经验分享：终于轮到我来分享经验l！这次投稿意料之外的快，可能是方向比较符合编辑的胃口，只送了一次外审，修回后就接收了，整个投稿流程也非常顺利，具体时间如下： * 11.08 submit * 11.11 改格式 * 11.14 under editor assessment * 11.15 reviewer invited + under review * 12.15 revise * 12.31 revise submit + with editor * 01.01 under editor assessment * 01.03 under review * 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191103, encodeId=96d6219110378, content=2.23日Under Editor Assessment 还没更新，会不会被拒。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4118494660, createdName=ms1000000105774578, createdTime=Tue Mar 05 09:29:50 CST 2024, time=2024-03-05, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿，现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：返修回去一个多月了，还是在邀请审稿人，难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片 12.25 submitted to journal 12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊，已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2139117, encodeId=8f50213911ec7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：请问Proof后多久才能出版呢，已经Proof两周了，没有动静，并且Pre-Online是未Proof版本，上周已邮件咨询过，回复是正在校稿，这快两周过去了，有知道情况的友友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eab8634806, createdName=ms6000000954293507, createdTime=Fri May 26 09:07:39 CST 2023, time=2023-05-26, status=1, ipAttribution=北京)]

33分钟前 1225f99em69(暂无昵称) 来自北京

前往app查看评论内容

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2168450, encodeId=9f872168450a0, content=偏重的研究方向：中药单体;心血管 经验分享：请问submitted状态要持续多久啊？我的已经2周没变过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Nov 14 13:52:58 CST 2023, time=2023-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122040, encodeId=eb54212204091, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：中药 经验分享：想请问大家，Under Editor Assessment这个状态卡了快一个月了，是什么意思呀，可以发邮件催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fc65556145, createdName=ms4000000742058182, createdTime=Mon Mar 27 11:02:07 CST 2023, time=2023-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=33分钟前, status=0, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理机制 经验分享：终于轮到我来分享经验l！这次投稿意料之外的快，可能是方向比较符合编辑的胃口，只送了一次外审，修回后就接收了，整个投稿流程也非常顺利，具体时间如下： * 11.08 submit * 11.11 改格式 * 11.14 under editor assessment * 11.15 reviewer invited + under review * 12.15 revise * 12.31 revise submit + with editor * 01.01 under editor assessment * 01.03 under review * 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191103, encodeId=96d6219110378, content=2.23日Under Editor Assessment 还没更新，会不会被拒。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4118494660, createdName=ms1000000105774578, createdTime=Tue Mar 05 09:29:50 CST 2024, time=2024-03-05, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿，现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：返修回去一个多月了，还是在邀请审稿人，难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片 12.25 submitted to journal 12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊，已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2139117, encodeId=8f50213911ec7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：请问Proof后多久才能出版呢，已经Proof两周了，没有动静，并且Pre-Online是未Proof版本，上周已邮件咨询过，回复是正在校稿，这快两周过去了，有知道情况的友友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eab8634806, createdName=ms6000000954293507, createdTime=Fri May 26 09:07:39 CST 2023, time=2023-05-26, status=1, ipAttribution=北京)]

2023-01-04 ms5000001894093922 来自北京

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：中药单体;药理机制
经验分享：终于轮到我来分享经验l！这次投稿意料之外的快，可能是方向比较符合编辑的胃口，只送了一次外审，修回后就接收了，整个投稿流程也非常顺利，具体时间如下：
* 11.08 submit
* 11.11 改格式
* 11.14 under editor assessment
* 11.15 reviewer invited + under review
* 12.15 revise
* 12.31 revise submit + with editor
* 01.01 under editor assessment
* 01.03 under review
* 01.04 accept

82 21

展开21条回复

[GetPortalCommentsPageByObjectIdResponse(id=2168450, encodeId=9f872168450a0, content=偏重的研究方向：中药单体;心血管 经验分享：请问submitted状态要持续多久啊？我的已经2周没变过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Nov 14 13:52:58 CST 2023, time=2023-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122040, encodeId=eb54212204091, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：中药 经验分享：想请问大家，Under Editor Assessment这个状态卡了快一个月了，是什么意思呀，可以发邮件催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fc65556145, createdName=ms4000000742058182, createdTime=Mon Mar 27 11:02:07 CST 2023, time=2023-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=33分钟前, status=0, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理机制 经验分享：终于轮到我来分享经验l！这次投稿意料之外的快，可能是方向比较符合编辑的胃口，只送了一次外审，修回后就接收了，整个投稿流程也非常顺利，具体时间如下： * 11.08 submit * 11.11 改格式 * 11.14 under editor assessment * 11.15 reviewer invited + under review * 12.15 revise * 12.31 revise submit + with editor * 01.01 under editor assessment * 01.03 under review * 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191103, encodeId=96d6219110378, content=2.23日Under Editor Assessment 还没更新，会不会被拒。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4118494660, createdName=ms1000000105774578, createdTime=Tue Mar 05 09:29:50 CST 2024, time=2024-03-05, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿，现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：返修回去一个多月了，还是在邀请审稿人，难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片 12.25 submitted to journal 12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊，已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2139117, encodeId=8f50213911ec7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：请问Proof后多久才能出版呢，已经Proof两周了，没有动静，并且Pre-Online是未Proof版本，上周已邮件咨询过，回复是正在校稿，这快两周过去了，有知道情况的友友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eab8634806, createdName=ms6000000954293507, createdTime=Fri May 26 09:07:39 CST 2023, time=2023-05-26, status=1, ipAttribution=北京)]

2024-03-05 ms1000000105774578 来自天津

2.23日Under Editor Assessment
还没更新，会不会被拒。。。

22 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2168450, encodeId=9f872168450a0, content=偏重的研究方向：中药单体;心血管 经验分享：请问submitted状态要持续多久啊？我的已经2周没变过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Nov 14 13:52:58 CST 2023, time=2023-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122040, encodeId=eb54212204091, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：中药 经验分享：想请问大家，Under Editor Assessment这个状态卡了快一个月了，是什么意思呀，可以发邮件催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fc65556145, createdName=ms4000000742058182, createdTime=Mon Mar 27 11:02:07 CST 2023, time=2023-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=33分钟前, status=0, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理机制 经验分享：终于轮到我来分享经验l！这次投稿意料之外的快，可能是方向比较符合编辑的胃口，只送了一次外审，修回后就接收了，整个投稿流程也非常顺利，具体时间如下： * 11.08 submit * 11.11 改格式 * 11.14 under editor assessment * 11.15 reviewer invited + under review * 12.15 revise * 12.31 revise submit + with editor * 01.01 under editor assessment * 01.03 under review * 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191103, encodeId=96d6219110378, content=2.23日Under Editor Assessment 还没更新，会不会被拒。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4118494660, createdName=ms1000000105774578, createdTime=Tue Mar 05 09:29:50 CST 2024, time=2024-03-05, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿，现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：返修回去一个多月了，还是在邀请审稿人，难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片 12.25 submitted to journal 12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊，已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2139117, encodeId=8f50213911ec7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：请问Proof后多久才能出版呢，已经Proof两周了，没有动静，并且Pre-Online是未Proof版本，上周已邮件咨询过，回复是正在校稿，这快两周过去了，有知道情况的友友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eab8634806, createdName=ms6000000954293507, createdTime=Fri May 26 09:07:39 CST 2023, time=2023-05-26, status=1, ipAttribution=北京)]

2024-03-25 ms2000000315947498 来自四川省

1.02投稿，现在还在under review...一点消息无。等的心焦

12 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2168450, encodeId=9f872168450a0, content=偏重的研究方向：中药单体;心血管 经验分享：请问submitted状态要持续多久啊？我的已经2周没变过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Nov 14 13:52:58 CST 2023, time=2023-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122040, encodeId=eb54212204091, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：中药 经验分享：想请问大家，Under Editor Assessment这个状态卡了快一个月了，是什么意思呀，可以发邮件催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fc65556145, createdName=ms4000000742058182, createdTime=Mon Mar 27 11:02:07 CST 2023, time=2023-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=33分钟前, status=0, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理机制 经验分享：终于轮到我来分享经验l！这次投稿意料之外的快，可能是方向比较符合编辑的胃口，只送了一次外审，修回后就接收了，整个投稿流程也非常顺利，具体时间如下： * 11.08 submit * 11.11 改格式 * 11.14 under editor assessment * 11.15 reviewer invited + under review * 12.15 revise * 12.31 revise submit + with editor * 01.01 under editor assessment * 01.03 under review * 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191103, encodeId=96d6219110378, content=2.23日Under Editor Assessment 还没更新，会不会被拒。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4118494660, createdName=ms1000000105774578, createdTime=Tue Mar 05 09:29:50 CST 2024, time=2024-03-05, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿，现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：返修回去一个多月了，还是在邀请审稿人，难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片 12.25 submitted to journal 12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊，已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2139117, encodeId=8f50213911ec7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：请问Proof后多久才能出版呢，已经Proof两周了，没有动静，并且Pre-Online是未Proof版本，上周已邮件咨询过，回复是正在校稿，这快两周过去了，有知道情况的友友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eab8634806, createdName=ms6000000954293507, createdTime=Fri May 26 09:07:39 CST 2023, time=2023-05-26, status=1, ipAttribution=北京)]

2024-04-17 ms8000001467150727 来自北京

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：肾脏病;中药复方
经验分享：返修回去一个多月了，还是在邀请审稿人，难受

1 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2168450, encodeId=9f872168450a0, content=偏重的研究方向：中药单体;心血管 经验分享：请问submitted状态要持续多久啊？我的已经2周没变过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Nov 14 13:52:58 CST 2023, time=2023-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122040, encodeId=eb54212204091, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：中药 经验分享：想请问大家，Under Editor Assessment这个状态卡了快一个月了，是什么意思呀，可以发邮件催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fc65556145, createdName=ms4000000742058182, createdTime=Mon Mar 27 11:02:07 CST 2023, time=2023-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=33分钟前, status=0, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理机制 经验分享：终于轮到我来分享经验l！这次投稿意料之外的快，可能是方向比较符合编辑的胃口，只送了一次外审，修回后就接收了，整个投稿流程也非常顺利，具体时间如下： * 11.08 submit * 11.11 改格式 * 11.14 under editor assessment * 11.15 reviewer invited + under review * 12.15 revise * 12.31 revise submit + with editor * 01.01 under editor assessment * 01.03 under review * 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191103, encodeId=96d6219110378, content=2.23日Under Editor Assessment 还没更新，会不会被拒。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4118494660, createdName=ms1000000105774578, createdTime=Tue Mar 05 09:29:50 CST 2024, time=2024-03-05, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿，现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：返修回去一个多月了，还是在邀请审稿人，难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片 12.25 submitted to journal 12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊，已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2139117, encodeId=8f50213911ec7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：请问Proof后多久才能出版呢，已经Proof两周了，没有动静，并且Pre-Online是未Proof版本，上周已邮件咨询过，回复是正在校稿，这快两周过去了，有知道情况的友友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eab8634806, createdName=ms6000000954293507, createdTime=Fri May 26 09:07:39 CST 2023, time=2023-05-26, status=1, ipAttribution=北京)]

2023-12-28 samtol 来自浙江省

让我修了两轮的格式和图片
12.25 submitted to journal
12.26 under editor assessment

37 26

展开26条回复

[GetPortalCommentsPageByObjectIdResponse(id=2168450, encodeId=9f872168450a0, content=偏重的研究方向：中药单体;心血管 经验分享：请问submitted状态要持续多久啊？我的已经2周没变过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Nov 14 13:52:58 CST 2023, time=2023-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122040, encodeId=eb54212204091, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：中药 经验分享：想请问大家，Under Editor Assessment这个状态卡了快一个月了，是什么意思呀，可以发邮件催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fc65556145, createdName=ms4000000742058182, createdTime=Mon Mar 27 11:02:07 CST 2023, time=2023-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=33分钟前, status=0, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理机制 经验分享：终于轮到我来分享经验l！这次投稿意料之外的快，可能是方向比较符合编辑的胃口，只送了一次外审，修回后就接收了，整个投稿流程也非常顺利，具体时间如下： * 11.08 submit * 11.11 改格式 * 11.14 under editor assessment * 11.15 reviewer invited + under review * 12.15 revise * 12.31 revise submit + with editor * 01.01 under editor assessment * 01.03 under review * 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191103, encodeId=96d6219110378, content=2.23日Under Editor Assessment 还没更新，会不会被拒。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4118494660, createdName=ms1000000105774578, createdTime=Tue Mar 05 09:29:50 CST 2024, time=2024-03-05, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿，现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：返修回去一个多月了，还是在邀请审稿人，难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片 12.25 submitted to journal 12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊，已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2139117, encodeId=8f50213911ec7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：请问Proof后多久才能出版呢，已经Proof两周了，没有动静，并且Pre-Online是未Proof版本，上周已邮件咨询过，回复是正在校稿，这快两周过去了，有知道情况的友友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eab8634806, createdName=ms6000000954293507, createdTime=Fri May 26 09:07:39 CST 2023, time=2023-05-26, status=1, ipAttribution=北京)]

2024-04-15 ms6000000634273240 来自四川省

请问proof返回后大概多久online啊，已经大半个月了还没有online🥹

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2168450, encodeId=9f872168450a0, content=偏重的研究方向：中药单体;心血管 经验分享：请问submitted状态要持续多久啊？我的已经2周没变过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Nov 14 13:52:58 CST 2023, time=2023-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2122040, encodeId=eb54212204091, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：中药 经验分享：想请问大家，Under Editor Assessment这个状态卡了快一个月了，是什么意思呀，可以发邮件催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fc65556145, createdName=ms4000000742058182, createdTime=Mon Mar 27 11:02:07 CST 2023, time=2023-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=33分钟前, status=0, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理机制 经验分享：终于轮到我来分享经验l！这次投稿意料之外的快，可能是方向比较符合编辑的胃口，只送了一次外审，修回后就接收了，整个投稿流程也非常顺利，具体时间如下： * 11.08 submit * 11.11 改格式 * 11.14 under editor assessment * 11.15 reviewer invited + under review * 12.15 revise * 12.31 revise submit + with editor * 01.01 under editor assessment * 01.03 under review * 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191103, encodeId=96d6219110378, content=2.23日Under Editor Assessment 还没更新，会不会被拒。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4118494660, createdName=ms1000000105774578, createdTime=Tue Mar 05 09:29:50 CST 2024, time=2024-03-05, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿，现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：返修回去一个多月了，还是在邀请审稿人，难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片 12.25 submitted to journal 12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊，已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2139117, encodeId=8f50213911ec7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：请问Proof后多久才能出版呢，已经Proof两周了，没有动静，并且Pre-Online是未Proof版本，上周已邮件咨询过，回复是正在校稿，这快两周过去了，有知道情况的友友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eab8634806, createdName=ms6000000954293507, createdTime=Fri May 26 09:07:39 CST 2023, time=2023-05-26, status=1, ipAttribution=北京)]

2023-05-26 ms6000000954293507 来自北京

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肾脏病;中药复方
经验分享：请问Proof后多久才能出版呢，已经Proof两周了，没有动静，并且Pre-Online是未Proof版本，上周已邮件咨询过，回复是正在校稿，这快两周过去了，有知道情况的友友吗？

46 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务